Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Kia Announces 2024 Annual and Fourth Quarter Business Results
Kia posts 2024 Q4 global sales of 769,985 units, a 5% increase…
Linkage Global Inc Announces Fiscal Year 2024 Financial Results
TOKYO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Linkage Global Inc (“Linkage Cayman”,…
Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) Compared to Opdivo Monotherapy…
Patients experienced a 38% reduction in the risk of disease progression or…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Kia Announces 2024 Annual and Fourth Quarter Business Results
Kia posts 2024 Q4 global sales of 769,985 units, a 5% increase…
Linkage Global Inc Announces Fiscal Year 2024 Financial Results
TOKYO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Linkage Global Inc (“Linkage Cayman”,…
U-Haul Holding Company Schedules Third Quarter Fiscal 2025 Financial Results Release and Investor Webcast
RENO, Nev.--(BUSINESS WIRE)--U-Haul Holding Company (NYSE: UHAL, UHAL.B), the parent company of…
Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results…
Kia Announces 2024 Annual and Fourth Quarter Business Results
Kia posts 2024 Q4 global sales of 769,985 units, a 5% increase…